Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03540368Completed
Randomised, double-blind trial in gastrointestinal bleeding comparing Tranexamic acid injection with Placebo (2 arms). Primary endpoint: Re-bleeding at 28 days. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03540368.